Abstract:Natural bisindole alkaloids such as Hyrtinadine A and Alocasin A, which are known to exhibit diverse bioactivities, provide promising chemical scaffolds for drug development. By optimizing the Masuda borylation–Suzuki coupling sequence, a library of various natural product-derived and non-natural (di)azine-bridged bisindoles was created. While unsubstituted bisindoles were devoid of antibacterial activity, 5,5′-chloro derivatives were highly active against methicillin-resistant Staphylococcus aureus (MRSA) and further Gram-positive pathogens at minimal inhibitory concentrations ranging from 0.20 to 0.78 μM. These compounds showed strong bactericidal killing effects but only moderate cytotoxicity against human cell lines. Furthermore, the two front-runner compounds 4j and 4n exhibited potent in vivo efficacy against MRSA in a mouse wound infection model. Although structurally related bisindoles were reported to specifically target pyruvate kinase in MRSA, antibacterial activity of 4j and 4n is independent of pyruvate kinase. Rather, these compounds lead to bacterial membrane permeabilization and cellular efflux of low-molecular-weight molecules.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00826?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00826</a>.MICs of compounds 4 against all tested bacteria strains (Table S1); cytotoxicity data of compounds 4j, 4n, and 4q against the human cell lines HEK293, HepG2, and CLS-54 (Table S2); SNPs present in MRSA resistant mutants (Table S3); MICs of compounds of different classes against MRSA resistant mutants and wild-type (Table S4); dose–response curve of compound 4r against MRSA (Figure S1); solubility assessment of compounds 4c, 4d, 4j, 4n, and 4r (Figure S2); absorption maxima of compounds 4c, 4d, 4j, 4n, and 4r (Figure S3); hemolytic activity of 4j and 4n on sheep red blood cells (Figure S4); stability evaluation of compound 4c (Figure S5); dose–response curves for 4d, 4n, 4q, and 4s against MRSA LAC WT and LAC Δpyk::ErmR in minimal medium M9 (Figure S6); studies describing optimization of reaction conditions (Scheme S1 and Table S5); analytical data of compounds 1a, 4a–4f, 4j, 4l–4n, 4p–4s, 4u, and 4v including 1H and 13C NMR spectra (Figures S7–S40) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00826/suppl_file/jm0c00826_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00826/suppl_file/jm0c00826_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Berichtigung: A Biosurfactant‐Inspired Heptapeptide with Improved Specificity to Kill MRSA

A New Synthetic Route to Avibactam: Lipase Catalytic Resolution and the Simultaneous Debenzylation/Sulfation

Bacilohydrin A, a New Cytotoxic Cyclic Lipopeptide of Surfactins Class Produced by Bacillus Sp. SY27F from the Indian Ocean Hydrothermal Vent

Berichtigung: Enantioselective Synthesis of Cyclopropanes That Contain Fluorinated Tertiary Stereogenic Carbon Centers: A Chiral Α‐fluoro Carbanion Strategy

In Memoriam: Donald N. Ross (1922–2014).

Surfactin effectively inhibits Staphylococcus aureus adhesion and biofilm formation on surfaces

Optimization of the Central α-Amino Acid in Cystobactamids to the Broad-Spectrum, Resistance-Breaking Antibiotic CN-CC-861

A new surfactin-C 17 produced by Bacillus subtilis TD7 with a low critical micelle concentration and high biological activities

Surfactant-tolerance evolution of Bacillus clausii protease for enhancing activity and stability by reshaping the substrate access tunnel

Chemical Approach for Investigation of the Structure‐Activity Relationship of Salmycin and Identification of a Glycan‐based Analogue for Drug Resistant Staphylococcus aureus

Design of a novel analogue peptide with potent antibiofilm activities against Staphylococcus aureus based upon a sapecin B-derived peptide

Effects of branched-chain amino acids on surfactin structure and antibacterial activity in Bacillus velezensis YA215

Manipulating Active Structure and Function of Cationic Antimicrobial Peptide CM15 with the Polysulfonated Drug Suramin: A Step Closer to in Vivo Complexity

The Antimicrobial Peptide Capitellacin: Chemical Synthesis of Analogues to Probe the Role of Disulphide Bridges and Their Replacement with Vinyl Sulphides

Evaluation of different Bacillus strains in respect of their ability to produce Surfactin in a model fermentation process with integrated foam fractionation

Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat Acinetobacter baumannii: From Screening Impurity to In Vivo Efficacy

Chemical structure, properties and potential applications of surfactin, as well as advanced strategies for improving its microbial production

Novel Antimicrobial Peptide SAAP Mutant as a Better Adjuvant to Sulbactam-Based Treatments Against Clinical Strains of XDR Acinetobacter baumannii

Nature-Inspired (di)Azine-Bridged Bisindole Alkaloids with Potent Antibacterial In Vitro and In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus

A novel antibiotic class targeting the lipopolysaccharide transporter

Genetic engineering of the branched‐chain fatty acid biosynthesis pathway to enhance surfactin production from Bacillus subtilis